clopidogrel and Dyslipidemia

clopidogrel has been researched along with Dyslipidemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Li, J; Li, X; Su, J; Wang, J; Xu, X; Yang, J; Yu, Q	1
De Kam, PJ; Lai, E; Luo, WL; Radziszewski, W; Ratcliffe, L; Royalty, J; Sisk, CM; Wagner, JA; Wenning, L	1
Armstrong, PW; Boden, WE; Fox, KA; Hafley, G; Hagström, E; Neely, ML; Ohman, EM; Prabhakaran, D; Roe, MT; Sidhu, MS; White, HD; Winters, KJ	1
Liao, JK	1

Reviews

1 review(s) available for clopidogrel and Dyslipidemia

Article	Year
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation, 2007, Mar-27, Volume: 115, Issue:12 Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents	2007

Article

Year

Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?

Circulation, 2007, Mar-27, Volume: 115, Issue:12

Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents

2007

Trials

2 trial(s) available for clopidogrel and Dyslipidemia

Article	Year
The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin. Platelets, 2014, Volume: 25, Issue:7 Topics: Adult; Aged; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Drug Interactions; Dyslipidemias; Female; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Young Adult	2014
Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial. Clinical cardiology, 2016, Volume: 39, Issue:6 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Biomarkers; Cholesterol, HDL; Clopidogrel; Down-Regulation; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2016

Article

Year

The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.

Platelets, 2014, Volume: 25, Issue:7

Topics: Adult; Aged; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Drug Interactions; Dyslipidemias; Female; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Young Adult

2014

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.

Clinical cardiology, 2016, Volume: 39, Issue:6

Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Biomarkers; Cholesterol, HDL; Clopidogrel; Down-Regulation; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome

2016

Other Studies

1 other study(ies) available for clopidogrel and Dyslipidemia

Article	Year
Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease. Journal of clinical laboratory analysis, 2019, Volume: 33, Issue:5 Topics: Aged; Aryldialkylphosphatase; Asian People; Clopidogrel; Coronary Artery Disease; CpG Islands; DNA Methylation; Drug Resistance; Dyslipidemias; Gene Expression Regulation; Humans; Middle Aged; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; Regression Analysis	2019

Article

Year

Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease.

Journal of clinical laboratory analysis, 2019, Volume: 33, Issue:5

Topics: Aged; Aryldialkylphosphatase; Asian People; Clopidogrel; Coronary Artery Disease; CpG Islands; DNA Methylation; Drug Resistance; Dyslipidemias; Gene Expression Regulation; Humans; Middle Aged; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; Regression Analysis

2019